Exploring the values, preferences, and information needs of patients with NKX2-1-related disorders: A qualitative study protocol

Background NKX2-1-related disorders have a prevalence of 1:500,000 and are therefore considered a rare condition according to the European Commission’s definition. The European Reference Network of Rare Neurological Disorders is developing the first clinical practice guideline on the management of this condition, with the support of the Andalusian Health Technology Assessment Area, Endo-ERN, ERN-Lung and Imegen, within the framework of the ERNs Guidelines programme (DG SANTE/2018/B3/030). Within the scope of this programme, it becomes necessary to explore the patient perspective in order to include it in the ongoing clinical practice guideline and accompanying patient information booklet. Methods and analysis This study will use qualitative methods to explore the values, preferences and information needs of patient with NKX2-1-related disorders and their caregivers. Participants will come from a variety of countries throughout Europe. One focus group and four semi-structured interviews will be conducted. Pairs will analyse the data using Grounded Theory. The Andalusian Regional Ministry of Health’s Ethics Coordinating Committee for Biomedical Research (Sevilla, Andalucía, Spain) has approved this study protocol (29/03/2022). Discussion This is the first study to explore the values, preferences, and information needs of patients with NKX2-1-related disorders. The proposed study’s findings will contribute to the generation of useful knowledge that will provide guidance to improve the care given to patients with the studied condition. While this study will provide valuable insights into the perspectives of patients with NKX2-1-related disorders, the findings are unlikely to be generalizable to patients with other conditions.

[1]  U. Surti,et al.  Deletion of conserved non‐coding sequences downstream from NKX2‐1: A novel disease‐causing mechanism for benign hereditary chorea , 2021, Molecular genetics & genomic medicine.

[2]  Beatrice Farrugia,et al.  WASP (write a scientific paper): Sampling in qualitative research. , 2019, Early human development.

[3]  J. Creswell,et al.  Journal article reporting standards for qualitative primary, qualitative meta-analytic, and mixed methods research in psychology: The APA Publications and Communications Board task force report. , 2018, The American psychologist.

[4]  R. Epaud,et al.  Heterogeneity of lung disease associated with NK2 homeobox 1 mutations. , 2017, Respiratory medicine.

[5]  S. Pfister,et al.  Recommendations for Cancer Surveillance in Individuals with RASopathies and Other Rare Genetic Conditions with Increased Cancer Risk , 2017, Clinical Cancer Research.

[6]  H. Schünemann,et al.  [GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction.] , 2017, Recenti progressi in medicina.

[7]  J. Huebner,et al.  Understandability of Patient Information Booklets for Patients with Cancer , 2018, Journal of Cancer Education.

[8]  K. Malterud,et al.  Sample Size in Qualitative Interview Studies , 2016, Qualitative health research.

[9]  Elie A Akl,et al.  GRADE Guidelines: 16. GRADE evidence to decision frameworks for tests in clinical practice and public health. , 2016, Journal of clinical epidemiology.

[10]  J. Jankovic,et al.  NKX2-1-Related Disorders , 2016 .

[11]  P. Giunti,et al.  Functional characterization of two novel mutations in TTF-1/NKX2.1 homeodomain in patients with benign hereditary chorea , 2016, Journal of the Neurological Sciences.

[12]  A. Kesselheim,et al.  Development and Use of New Therapeutics for Rare Diseases: Views from Patients, Caregivers, and Advocates , 2015, The Patient - Patient-Centered Outcomes Research.

[13]  H. Ropers,et al.  Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum , 2014, Journal of Medical Genetics.

[14]  Rachael Fleurence,et al.  How the Patient-Centered Outcomes Research Institute is engaging patients and others in shaping its research agenda. , 2013, Health affairs.

[15]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[16]  R. Rosenfeld,et al.  Authority , 2010, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[17]  P. Tam,et al.  A germline mutation (A339V) in thyroid transcription factor-1 (TITF-1/NKX2.1) in patients with multinodular goiter and papillary thyroid carcinoma. , 2009, Journal of the National Cancer Institute.

[18]  P. Sainsbury,et al.  Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. , 2007, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[19]  J. L. Yntema,et al.  Brain-Thyroid-Lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene , 2005, European Journal of Pediatrics.

[20]  A. Strauss,et al.  The discovery of grounded theory: strategies for qualitative research aldine de gruyter , 1968 .